Significantly higher frequencies of tumor-infiltrating CD8+ cells expressed CD103 in P-M than P-NM cSCCs (median 35.0% vs 20.4%, respectively, p<0.0001, figure 6F). This evidence concerns the gene CD8A and neoplasm.